Peer-influenced content. Sources you trust. No registration required. This is HCN.
Oncology News Central (ONC)
The FDA has withdrawn approval for infigratinib in advanced cholangiocarcinoma following Helsinn Healthcare SA’s request, citing recruitment difficulties for a confirmatory trial.
Oncology, Medical June 17th 2024
Epoch Health
The FDA has recalled Abbott’s HeartMate 3 LVAD after reports of severe complications during implantation, including blood leakage and air entry, which can lead to serious surgical risks.
Cardiology June 5th 2024
GoodRx for Healthcare Professionals
With no reported illnesses yet from the FDA’s recall of specific ground cinnamon products for lead contamination, the focus remains on preventing long-term exposure, particularly in children.
All Specialties June 4th 2024
HIT Consultant
Philips Respironics has established a consent decree with US regulators to ensure the safety and compliance of their sleep and respiratory care devices, focusing on stringent remediation and continued patient support amidst ongoing sales restrictions.
Internal Medicine April 22nd 2024
Healthcare providers should be alert to symptoms of methanol poisoning, which can include vomiting, blurred vision, and seizures, particularly in patients who may have used recalled hand sanitizers containing methanol.
All Specialties April 16th 2024
Pharmacy Learning Network
Ensure patient safety and treatment efficacy with awareness of the recent recall of omeprazole and sodium bicarbonate powder, essential for treating critical gastrointestinal conditions.
Gastroenterology March 18th 2024